Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margaret A Schwarz

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Experimental Cell Research|May 6, 2006
Identification of protease-sensitive sites in Human Endothelial-Monocyte Activating Polypeptide II proteinJie Liu, Margaret A Schwarz
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 14, 2015
Adapted approach to profile genes while reconciling Vegf-a mRNA expression in the developing and injured lungDaniel D Lee, Margaret A Schwarz
The Journal of Surgical Research|June 3, 2004
In vivo therapy of local tumor progression by targeting vascular endothelium with EMAP-IIRoderich E Schwarz, Margaret A Schwarz
Birth Defects Research. Part A, Clinical and Molecular Teratology|March 13, 2014
Vascular mediators in chronic lung disease of infancy: role of endothelial monocyte activating polypeptide II (EMAP II)Charitharth Vivek Lal, Margaret A Schwarz
Critical Care Clinics|March 17, 2020
Cell-Cell Communication Breakdown and Endothelial DysfunctionDaniel D Lee, Margaret A Schwarz
Cancer Chemotherapy and Pharmacology|November 27, 2010
Enhancing cytotoxic agent activity in experimental pancreatic cancer through EMAP II combination therapyNiranjan Awasthi, Margaret A Schwarz, Roderich E Schwarz
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 17, 2011
Antitumour activity of sunitinib in combination with gemcitabine in experimental pancreatic cancerNiranjan Awasthi, Margaret A Schwarz, Roderich E Schwarz
Cancer Biology & Therapy|May 25, 2010
Combination effects of bortezomib with gemcitabine and EMAP II in experimental pancreatic cancerNiranjan Awasthi, Margaret A Schwarz, Roderich E Schwarz
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 25, 2010
Proteasome inhibition enhances antitumour effects of gemcitabine in experimental pancreatic cancerNiranjan Awasthi, Margaret A Schwarz, Roderich E Schwarz
Biochemical Pharmacology|September 12, 2022
Integrating epigenetics and metabolomics to advance treatments for pulmonary arterial hypertensionA Dushani C U Ranasinghe, Margaret A Schwarz
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Experimental Cell Research|May 6, 2006
Identification of protease-sensitive sites in Human Endothelial-Monocyte Activating Polypeptide II proteinJie Liu, Margaret A Schwarz
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 14, 2015
Adapted approach to profile genes while reconciling Vegf-a mRNA expression in the developing and injured lungDaniel D Lee, Margaret A Schwarz
The Journal of Surgical Research|June 3, 2004
In vivo therapy of local tumor progression by targeting vascular endothelium with EMAP-IIRoderich E Schwarz, Margaret A Schwarz
Birth Defects Research. Part A, Clinical and Molecular Teratology|March 13, 2014
Vascular mediators in chronic lung disease of infancy: role of endothelial monocyte activating polypeptide II (EMAP II)Charitharth Vivek Lal, Margaret A Schwarz
Critical Care Clinics|March 17, 2020
Cell-Cell Communication Breakdown and Endothelial DysfunctionDaniel D Lee, Margaret A Schwarz
Cancer Chemotherapy and Pharmacology|November 27, 2010
Enhancing cytotoxic agent activity in experimental pancreatic cancer through EMAP II combination therapyNiranjan Awasthi, Margaret A Schwarz, Roderich E Schwarz
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 17, 2011
Antitumour activity of sunitinib in combination with gemcitabine in experimental pancreatic cancerNiranjan Awasthi, Margaret A Schwarz, Roderich E Schwarz
Cancer Biology & Therapy|May 25, 2010
Combination effects of bortezomib with gemcitabine and EMAP II in experimental pancreatic cancerNiranjan Awasthi, Margaret A Schwarz, Roderich E Schwarz
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 25, 2010
Proteasome inhibition enhances antitumour effects of gemcitabine in experimental pancreatic cancerNiranjan Awasthi, Margaret A Schwarz, Roderich E Schwarz
Biochemical Pharmacology|September 12, 2022
Integrating epigenetics and metabolomics to advance treatments for pulmonary arterial hypertensionA Dushani C U Ranasinghe, Margaret A Schwarz
Pageof 7